• Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
  • Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, PGDx elio™ Assay)
  • Gamma Glutamyl Transferase (GGT)
  • MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • LiquidHALLMARK Multi Cancer Panel
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Serum
Medical Test

Diseases (28)
Access to Cancer Antigen (CA) 19-9, Serum is restricted.
Loading...